Physician profile
Gail E Sowa
NPI 1780786251
$1,589.57
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $280 · 2021: $333 · 2022: $177 · 2023: $212 · 2024: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $544.81 | 2019-2023 | Liletta, Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $202.01 | 2019-2024 | Veozah |
| Allergan, INC. | $109.81 | 2019 | |
| Coopersurgical, INC. | $83.61 | 2019-2024 | Paragard T 380a |
| Ethicon US, LLC | $73.11 | 2020-2023 | Surgicel Nu-Knit |
| Organon LLC | $70.09 | 2021-2022 | |
| Myovant Sciences INC. | $61.22 | 2021-2022 | |
| Therapeuticsmd, INC. | $60.06 | 2019-2021 | |
| Duchesnay USA Incorporated | $49.54 | 2019 | |
| Mayne Pharma Commercial LLC | $47.44 | 2023 | |
| Pfizer INC. | $43.58 | 2019 | |
| Roche Diagnostics Corporation | $40.38 | 2019 | |
| Sumitomo Pharma America, INC. | $33.47 | 2023 | Myfembree |
| Amag Pharmaceuticals, INC. | $31.40 | 2019 | |
| Merck Sharp & Dohme LLC | $29.97 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $21.57 | 2020 | |
| Evofem Biosciences, INC. | $20.13 | 2021 | |
| Aspira Women'S Health INC | $18.36 | 2024 | Ova1 |
| Mycovia Pharmaceuticals, INC. | $17.09 | 2023 | Vivjoa |
| Ascend Therapeutics US, LLC | $16.97 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gail Sowa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.